InvestorsHub Logo
Followers 213
Posts 6066
Boards Moderated 1
Alias Born 01/07/2015

Re: Amatuer17 post# 17709

Tuesday, 10/17/2017 7:10:30 AM

Tuesday, October 17, 2017 7:10:30 AM

Post# of 232336
Everyone here knew the face to face fda meeting was to raise the number of patients in the trial, it was in a press release last month. The Ibalizumab trial had 50, so it was a safe bet that was the number. What surprised me was the 40 enrollment in combo, after relaxing the trial last month, I was hoping it was closer to 50 as they were already adding 3 per month without that relaxation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News